close

Enter

Log in using OpenID

Bipolar Disorders Treatment Market Revenue Growth Predicted by 2026

embed
Bipolar disorder is related to mental health and can be characterized as drastic changes in mood, energy levels, and ability to perform daily tasks. The mood typically shows two types of episodes – manic and depression.
Bipolar Disorders Treatment Market Anlysis with
Inputs from Industry Experts 2018 to 2026
Bipolar Disorders Treatment Market, By Drug Class (Mood Stabilizer (Lithium),
Antipsychotics (Aripiprazole, Olanzapine, Quetiapine, and Paliperidone),
Antidepressants (Citalopram, Escitalopram, Fluoxetine, Paroxetine, and
Sertraline), Anticonvulsant (Valproate, Carbamazepine, and Lamotrigine), and
Others), by Route of Administration (Oral, Intramuscular, and Intravenous), by
Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online
Pharmacies), and by Region (North America, Europe, Latin America, Asia
Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity
Analysis, 2018 - 2026
Bipolar disorder is related to mental health and can be characterized as drastic changes in mood, energy
levels, and ability to perform daily tasks. The mood typically shows two types of episodes – manic and
depression. There are four types of bipolar disorders: Bipolar I, Bipolar II, Cyclothymic, and other
specified and non-specified bipolar and related disorders. All these types show similar symptoms but
the severity varies. Bipolar disorder can be treated with treatments such as mood stabilizers,
antipsychotics, antidepressants, and anticonvulsants. Click To Read More On Bipolar Disorders
Treatment Market.
Global Bipolar Disorders Treatment Market Drivers
Key players in the global bipolar disorder treatment market are focusing on research and development
of novel drugs that aid in the treatment of bipolar disorders. This in turn is expected to drive the global
bipolar disorder market growth. For instance, in February 2019, Otsuka Holdings Co. Ltd. reported
Phase III clinical trial evaluation of brexpiprazole for the treatment of manic attacks in bipolar disorder
I. The study was conducted to confirm the effectiveness of brexpiprazole for a duration of 2-3 weeks, in
double-blind and placebo-controlled trials. It was found that the drug was well tolerated by the patients.
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/2605
Furthermore, in July 2018, a team of researchers from Novartis International AG studied on digital
measurement tools for bipolar disorders so that accurate drug can be given for an effective treatment.
Until now, these disorders are identified by conventional methods and no definitive tool is available,
which tests the spinal fluid present in the brain. According to the researchers, these digital measurement
tools may help in diagnosis of bipolar disorder and will increase the efficacy of drugs.
Moreover, intervention of medical adherence tools (such as electronic adherence monitoring devices) to
increase treatment adherence in patients with bipolar disorders may improve outcomes in the treatment
of bipolar disorder patients. It ensures that medication is properly taken and it is done so by ways such
as psychoeducational and family communication interventions, cognitive behavior therapy,
manipulating the packaging of the drugs, simplifying a dosage regimen with pill boxes, medication
organizers, blister packaging, or coordinating dosage times with the daily activities of patients.
Global Bipolar Disorders Treatment Market Key Players
Some of the major players operating in the global bipolar disorder treatment market include, Pfizer
Inc., Eli Lilly and Co, Apotex Technology Inc., AbbVie Inc., Novartis AG, Otsuka holdings co. Ltd.,
GlaxoSmithKline LLC, AstraZeneca, Allergan plc., and Janssen Pharmaceuticals Inc.
Global Bipolar Disorders Treatment Market Regional Analysis
North America is expected to hold dominant position in the global bipolar disorder treatment market.
Presence of leading manufacturers such as Eli Lilly and Co., Pfizer Inc., and AbbVie Inc in the region
has supported North America bipolar disorders treatment market. Moreover, ongoing research and
development in bipolar disorder treatments by companies such as Sage Therapeutics is expected to
support North America bipolar disorders treatment market growth over the forecast period. For
instance, Sage Therapeutics is working on Sage-217 drug for major depressive episode of bipolar
disorder. The drug has completed phase-II of clinical trials in March 2019. Such key developments are
expected to boost the global bipolar disorder treatment market growth.
Furthermore, key players from other markets have also received approvals for their novel products in
the U.S. For instance, Allergan (Ireland-based company) received Supplemental New Drug Application
(sNDA) expansion on Varylar in 2017, which aids in the treatment of bipolar disorders.
Moreover, increasing initiatives from various governments and organizations to spread awareness
regarding mental health also supports the global bipolar disorders treatment market growth. For
instance, Mental Health America celebrates the month of May as the Mental Awareness Month. The
organization offers various other organizations a toolkit designed for the patients with chronic
conditions. These factors are expected to support global bipolar disorders treatment market growth over
the forecast period.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]
Author
ravikiran
ravikiran221   document Email
Document
Category
Health and Medicine
Views
1
File Size
367 KB
Tags
treatment
1/--pages
Report inappropriate content